Research

Health Minister Helen Whately tries breath testing kit with Professor George Hanna
Research

World-first pancreatic cancer breath test

11 March 2023

We’re thrilled to announce that we are funding a new clinical study to develop a breath test that could detect pancreatic cancer early enough to save thousands of lives a year.

Two female researchers working in a lab wearing purples gloves and using a pipette
Research

Four things we’ve learnt about early detection

22 February 2023

Our researchers have laid the vital groundwork for the development of new tests for the early detection of pancreatic cancer. Here we take a look at what they have achieved so far. 

Research

Pancreatic Cancer UK Discovery and Translational Research Forum, 26 & 27 June 2023

Female researcher carrying out some work in a lab.
Research

Cambridge researchers to improve treatment options for deadliest common cancer by understanding how it grows

21 December 2022

Researchers at the University of Cambridge will use a new cutting-edge laboratory technique to study which proteins cause uncontrolled cell-growth in pancreatic cancer and enable the devastating disease to spread rapidly.

A machine delivering chemotherapy through an intravenous drip.
Research

Chemo before surgery shown to improve one-year survival

19 December 2022

A new clinical trial has found that chemotherapy before surgery significantly increased the one-year survival of people with pancreatic cancer whose tumour was borderline resectable. 

Scientist Professor Robin Ketteler standing in a lab with two of his colleagues looking at a sample
Research

The realities of research

7 October 2022

Research into pancreatic cancer has been underfunded and under-resourced for decades, resulting in little improvement in survival rates for this devastating disease. Here’s how we're taking that on.

Research

New blood test to detect cancer

24 August 2022

Our CEO at Pancreatic Cancer UK, Diana Jupp has provided commentary on the new blood test that aims to detect more than 50 types of cancer before symptoms arise. 

Three researchers working in a lab wearing their white lab coats
Research

How your support is funding world-class research

23 August 2022

In 2021/22, your support meant that we could fund £1.8m in research grants – more than ever before – bringing our total research spend to £10m. Our Head of Research, Dr Chris MacDonald, explains how we’re using this money to give our researchers the best chance of making breakthroughs.

Research

New hope for treating pancreatic cancer: Targeting the ‘recycler’ protein USP25

7 July 2022

An innovative new study may revolutionise pancreatic cancer therapy by targeting the ‘recycler’ protein USP25 to reduce the growth of cancer cells.

Research

Our response to “gremlin therapy” research that suggests pancreatic cancer can be reversed

30 June 2022

New research from the Institute of Cancer Research suggests that it could be possible to reverse a key process that enables pancreatic cancer cells to grow and spread in the body.

 

Our Research Involvement Network: Shaping the future of pancreatic cancer research

28 June 2022

Dr Naureen Starling is a Consultant Medical Oncologist at the Royal Marsden NHS Foundation Trust specialising in the treatment of gastrointestinal cancers, as well as researching new therapies.

Research

Our response to the mRNA pancreatic cancer vaccine trial

8 June 2022

Our Head of Research, Dr Chris MacDonald comments on the exciting trial results presented at the American Society of Clinical Oncology conference in Chicago.